Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A

Human Molecular Genetics

Volumn 22, Issue 1, 2013, Pages 74-83

  Szemes, Marianna ^a   Dallosso, Anthony R ^a   Melegh, Zsombor ^b   Curry, Thomas ^a   Li, Yifan ^a,d   Rivers, Caroline ^a   Uney, James ^a   Mágdefrau, Ann Sophie ^a   Schwiderski, Karolin ^a   Park, Ji H ^a   Brown, Keith W ^a   Shandilya, Jayasha ^c   Roberts, Stefan G E ^a   Malik, Karim ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c UNIVERSITY AT BUFFALO   (United States)

^d Shenzhen Nanshan People s Hospital and the 6th Affiliated Hospital of Shenzhen University Medical School   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA METHYLTRANSFERASE 3A; EARLY GROWTH RESPONSE FACTOR 1; PROTEIN MLH1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSFORMING GROWTH FACTOR BETA2; WT1 PROTEIN;

ARTICLE; CELL NUCLEUS; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; HUMANS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; WILMS TUMOR; WT1 PROTEINS;

EID: 84871257372     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds403     Document Type: Article

References (61)

1. Lotem, J. and Sachs, L. (2006) Epigenetics and the plasticity of differentiation in normal and cancer stem cells. Oncogene, 25, 7663-7672.
2. Brenner, C., Deplus, R., Didelot, C., Loriot, A., Vire, E., De Smet, C., Gutierrez, A., Danovi, D., Bernard, D., Boon, T. et al. (2005) Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J., 24, 336-346.
3. Zhang, Q., Wang, H.Y., Marzec, M., Raghunath, P.N., Nagasawa, T. and Wasik, M.A. (2005) STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc. Natl Acad. Sci. USA, 102, 6948-6953.
4. Zhang, Q., Wang, H.Y., Woetmann, A., Raghunath, P.N., Odum, N. and Wasik, M.A. (2006) STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood, 108, 1058-1064.
5. Puto, L.A. and Reed, J.C. (2008) Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev., 22, 998-1010.
6. Palakurthy, R.K., Wajapeyee, N., Santra, M.K., Gazin, C., Lin, L., Gobeil, S. and Green, M.R. (2009) Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression. Mol. Cell, 36, 219-230.
7. Gowher, H., Stuhlmann, H. and Felsenfeld, G. (2008) Vezf1 regulates genomic DNA methylation through its effects on expression of DNA methyltransferase Dnmt3b. Genes Dev., 22, 2075-2084.
8. Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., Housman, D. and Jaenisch, R. (1993) WT-1 is required for early kidney development. Cell, 74, 679-691.
9. Ijpenberg, A., Perez-Pomares, J.M., Guadix, J.A., Carmona, R., Portillo-Sanchez, V., Macias, D., Hohenstein, P., Miles, C.M., Hastie, N.D. and Munoz-Chapuli, R. (2007) Wt1 and retinoic acid signaling are essential for stellate cell development and liver morphogenesis. Dev. Biol., 312, 157-170.
10. Wagner, K.D., Wagner, N., Vidal, V.P., Schley, G., Wilhelm, D., Schedl, A., Englert, C. and Scholz, H. (2002) The Wilms' tumor gene Wt1 is required for normal development of the retina. EMBO J., 21, 1398-1405.
11. Hammes, A., Guo, J.K., Lutsch, G., Leheste, J.R., Landrock, D., Ziegler, U., Gubler, M.C. and Schedl, A. (2001) Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell, 106, 319-329.
12. Martinez-Estrada, O.M., Lettice, L.A., Essafi, A., Guadix, J.A., Slight, J., Velecela, V., Hall, E., Reichmann, J., Devenney, P.S., Hohenstein, P. et al. (2010) Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat. Genet., 42, 89-93.
13. Rivera, M.N. and Haber, D.A. (2005) Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat. Rev. Cancer, 5, 699-712.
14. Yang, L., Han, Y., Suarez Saiz, F. and Minden, M.D. (2007) A tumor suppressor and oncogene: the WT1 story. Leukemia, 21, 868-876.
15. Clark, A.J., Ware, J.L., Chen, M.Y., Graf, M.R., Van Meter, T.E., Dos Santos, W.G., Fillmore, H.L. and Broaddus, W.C. (2009) Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells. J. Neurosurg., 112, 18-25.
16. Wagner, N., Panelos, J., Massi, D. and Wagner, K.D. (2008) The Wilms' tumor suppressor WT1 is associated with melanoma proliferation. Pflugers Arch., 455, 839-847.
17. Perugorria, M.J., Castillo, J., Latasa, M.U., Goni, S., Segura, V., Sangro, B., Prieto, J., Avila, M.A. and Berasain, C. (2009) Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. Cancer Res., 69, 1358-1367.
18. Roberts, S.G. (2005) Transcriptional regulation by WT1 in development. Curr. Opin. Genet. Dev., 15, 542-547.
19. Wagner, N., Wagner, K.D., Xing, Y., Scholz, H. and Schedl, A. (2004) The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1. J. Am. Soc. Nephrol., 15, 3044-3051.
20. Dallosso, A.R., Hancock, A.L., Brown, K.W., Williams, A.C., Jackson, S. and Malik, K. (2004) Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours. Hum. Mol. Genet., 13, 405-415.
21. Essafi, A., Webb, A., Berry, R.L., Slight, J., Burn, S.F., Spraggon, L., Velecela, V., Martinez-Estrada, O.M., Wiltshire, J.H., Roberts, S.G. et al. (2011) A Wt1-controlled chromatin switching mechanism underpins tissue-specific wnt4 activation and repression. Dev. Cell, 21, 559-574.
22. Xu, B., Zeng, D.Q., Wu, Y.A., Zheng, R., Gu, L., Lin, X.A., Hua, X.X. and Jin, G.H. (2011) Tumor Suppressor Menin Represses Paired Box Gene 2 expression via Wilms tumor suppressor protein-polycomb group complex. J. Biol. Chem., 286, 13937-13944.
23. Okano, M., Bell, D.W., Haber, D.A. and Li, E. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99, 247-257.
24. Chedin, F., Lieber, M.R. and Hsieh, C.L. (2002) The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proc. Natl Acad. Sci. USA, 99, 16916-16921.
25. Chen, T.P., Ueda, Y., Xie, S.P. and Li, E. (2002) A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J. Biol. Chem., 277, 38746-38754.
26. Yanagisawa, Y., Ito, E., Yuasa, Y. and Maruyama, K. (2002) The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents. Biochim. Biophys. Acta Gene Struct. Exp., 1577, 457-465.
27. Hartwig, S., Ho, J., Pandey, P., Macisaac, K., Taglienti, M., Xiang, M., Alterovitz, G., Ramoni, M., Fraenkel, E. and Kreidberg, J.A. (2010) Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development. Development, 137, 1189-1203.
28. Han, Y., Yang, L., Suarez-Saiz, F., San-Marina, S., Cui, J. and Minden, M.D. (2008) Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells. Mol. Cancer Res., 6, 1347-1355.
29. Robertson, K.D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F.A. and Jones, P.A. (1999) The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res., 27, 2291-2298.
30. Deng, T., Kuang, Y., Wang, L., Li, J., Wang, Z. and Fei, J. (2009) An essential role for DNA methyltransferase 3a in melanoma tumorigenesis. Biochem. Biophys. Res. Commun., 387, 611-616.
31. Bai, X., Song, Z., Fu, Y., Yu, Z., Zhao, L., Zhao, H., Yao, W., Huang, D., Mi, X., Wang, E. et al. (2012) Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer. PLoS ONE, 7, e40024.
32. Qu, Y., Mu, G.Y., Wu, Y.W., Dai, X., Zhou, F., Xu, X.Y., Wang, Y. and Wei, F.C. (2012) Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis. Am. J. Clin. Path., 134, 826-834.
33. Li, H.W., Rauch, T., Chen, Z.X., Szabo, P.E., Riggs, A.D. and Pfeifer, G.P. (2006) The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J. Biol. Chem., 281, 19489-19500.
34. Wu, H., Coskun, V., Tao, J., Xie, W., Ge, W., Yoshikawa, K., Li, E., Zhang, Y. and Sun, Y.E. (2010) Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science, 329, 444-448.
35. Dallosso, A.R., Hancock, A.L., Szemes, M., Moorwood, K., Chilukamarri, L., Tsai, H.H., Sarkar, A., Barasch, J., Vuononvirta, R., Jones, C. et al. (2009) Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor. PLoS Genet., 5, e1000745. doi:1000710.1001371/journal.pgen.1000745.
36. Dallosso, A.R., Oster, B., Greenhough, A., Thorsen, K., Curry, T.J., Owen, C., Hancock, A.L., Szemes, M., Paraskeva, C., Frank, M. et al. (2012) Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene, [advance online publication].
37. Hocevar, B.A., Brown, T.L. and Howe, P.H. (1999) TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J., 18, 1345-1356.
38. Hohenstein, P. and Hastie, N.D. (2006) The many facets of the Wilms' tumour gene, WT1. Hum. Mol. Genet., 15(Spec No. 2), R196-R201.
39. Miremadi, A., Oestergaard, M.Z., Pharoah, P.D.P. and Caldas, C. (2007) Cancer genetics of epigenetic genes. Hum. Mol. Genet., 16, R28-R49.
40. Esteller, M. (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet., 8, 286-298.
41. Jinawath, A., Miyake, S., Yanagisawa, Y., Akiyama, Y. and Yuasa, Y. (2005) Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins. Biochem. J., 385, 557-564.
42. Shaw, G., Morse, S., Ararat, M. and Graham, F.L. (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J., 16, 869-871.
43. Thedieck, C., Kalbacher, H., Kuczyk, M., Muller, G.A., Muller, C.A. and Klein, G. (2007) Cadherin-9 is a novel cell surface marker for the heterogeneous pool of renal fibroblasts. PLoS ONE, 2, e657.
44. Chrast, R., Scott, H.S., Chen, H., Kudoh, J., Rossier, C., Minoshima, S., Wang, Y., Shimizu, N. and Antonarakis, S.E. (1997) Cloning of two human homologs of the Drosophila single-minded gene SIM1 on chromosome 6q and SIM2 on 21q within the Down syndrome chromosomal region. Genome Res., 7, 615-624.
45. Linhart, H.G., Lin, H., Yamada, Y., Moran, E., Steine, E.J., Gokhale, S., Lo, G., Cantu, E., Ehrich, M., He, T. et al. (2007) Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev., 21, 3110-3122.
46. Hajkova, H., Markova, J., Haskovec, C., Sarova, I., Fuchs, O., Kostecka, A., Cetkovsky, P., Michalova, K. and Schwarz, J. (2012) Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation. Leuk. Res., [advance online publication].
47. Gao, Q., Steine, E.J., Barrasa, M.I., Hockemeyer, D., Pawlak, M., Fu, D.D., Reddy, S., Bell, G.W. and Jaenisch, R. (2011) Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression. Proc. Natl Acad. Sci. USA, 108, 18061-18066.
48. Li, B.Z., Huang, Z., Cui, Q.Y., Song, X.H., Du, L., Jeltsch, A., Chen, P., Li, G., Li, E. and Xu, G.L. (2011) Histone tails regulate DNA methylation by allosterically activating de novo methyltransferase. Cell Res., 21, 1172-1181.
49. McGarvey, K.M., Greene, E., Fahrner, J.A., Jenuwein, T. and Baylin, S.B. (2007) DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2. Cancer Res., 67, 5097-5102.
50. Lembo, F., Pero, R., Angrisano, T., Vitiello, C., Iuliano, R., Bruni, C.B. and Chiariotti, L. (2003) MBDin, a novel MBD2-interacting protein, relieves MBD2 repression potential and reactivates transcription from methylated promoters. Mol. Cell Biol., 23, 1656-1665.
51. Fuks, F., Burgers, W.A., Godin, N., Kasai, M. and Kouzarides, T. (2001) Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J., 20, 2536-2544.
52. Raynal, N.J., Si, J., Taby, R.F., Gharibyan, V., Ahmed, S., Jelinek, J., Estecio, M.R. and Issa, J.P. (2012) DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory. Cancer Res., 72, 1170-1181.
53. Liu, L., Kron, K.J., Pethe, V.V., Demetrashvili, N., Nesbitt, M.E., Trachtenberg, J., Ozcelik, H., Fleshner, N.E., Briollais, L., van der Kwast, T.H. et al. (2011) Association of tissue promoter methylation levels of APC, TGFbeta2, HOXD3 and RASSF1A with prostate cancer progression. Int. J. Cancer, 129, 2454-2462.
54. Elliott, R.L. and Blobe, G.C. (2005) Role of transforming growth factor Beta in human cancer. J. Clin. Oncol., 23, 2078-2093.
55. Li, C.M., Kim, C.E., Margolin, A.A., Guo, M., Zhu, J., Mason, J.M., Hensle, T.W., Murty, V.V., Grundy, P.E., Fearon, E.R. et al. (2004) CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors. Am. J. Pathol., 165, 1943-1953.
56. Yu, M., Smolen, G.A., Zhang, J., Wittner, B., Schott, B.J., Brachtel, E., Ramaswamy, S., Maheswaran, S. and Haber, D.A. (2009) A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. Genes Dev., 23, 1737-1742.
57. Burwell, E.A., McCarty, G.P., Simpson, L.A., Thompson, K.A. and Loeb, D.M. (2007) Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells. Oncogene, 26, 3423-3430.
58. Metivier, R., Gallais, R., Tiffoche, C., Le Peron, C., Jurkowska, R.Z., Carmouche, R.P., Ibberson, D., Barath, P., Demay, F., Reid, G. et al. (2008) Cyclical DNA methylation of a transcriptionally active promoter. Nature, 452, 45-50.
59. Kangaspeska, S., Stride, B., Metivier, R., Polycarpou-Schwarz, M., Ibberson, D., Carmouche, R.P., Benes, V., Gannon, F. and Reid, G. (2008) Transient cyclical methylation of promoter DNA. Nature, 452, 112-115.
60. Strathdee, C.A., McLeod, M.R. and Hall, J.R. (1999) Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector. Gene, 229, 21-29.
61. Gebhard, C., Schwarzfischer, L., Pham, T.H., Schilling, E., Klug, M., Andreesen, R. and Rehli, M. (2006) Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res., 66, 6118-6128.